Company Filing History:
Years Active: 2023
Title: Celebrating Innovation: Anna Maria Steiner and Her Patented Antibody Formulations
Introduction: Anna Maria Steiner, an accomplished inventor based in Eberhardzell, Germany, has made notable contributions to the field of biotechnology. With a keen focus on antibody formulations, she holds a patent that exemplifies her dedication to innovative solutions in medicine.
Latest Patents: Anna Maria is credited with one significant patent titled "Anti-IL-36R Antibody Formulations." This patent concerns the development of antibody formulations aimed at targeting the interleukin-36 receptor (IL-36R) for administration to subjects, underscoring her impactful work in therapeutic development.
Career Highlights: Working at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company, Anna Maria continues to push the boundaries of scientific research and innovation. Her expertise in antibody development has had a profound impact on drug formulation strategies, contributing to advancements in therapeutic applications.
Collaborations: Throughout her career, Anna Maria has collaborated with talented colleagues such as Sandra Nicole Denkinger and Derrick Spencer Katayama. These partnerships highlight her dedication to teamwork and the importance of collaboration in driving significant scientific discoveries and innovations.
Conclusion: Anna Maria Steiner stands out as a key figure in the biotechnology sector, with her patent for anti-IL-36R antibody formulations marking a significant achievement in her career. Her work at Boehringer Ingelheim International GmbH, along with her collaborative efforts, showcases her commitment to advancing medical science and innovating for the betterment of healthcare.